Ruben Bill
Geneve, GE, Switzerland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 29 publications
CCL3 is produced by aged neutrophils across cancers and promotes tumor growth.
Journal: Cancer cell
Published: July 09, 2025
Chrono-immunotherapy as a low-hanging fruit for cancer treatment? A call for pragmatic randomized clinical trials.
Journal: Journal for immunotherapy of cancer
Published: February 12, 2025
Response to induction chemotherapy as a prognostic indicator in locally advanced head and neck squamous cell carcinoma.
Journal: Journal of cancer research and clinical oncology
Published: September 16, 2024
Circadian tumor infiltration and function of CD8+ T cells dictate immunotherapy efficacy.
Journal: Cell
Published: October 12, 2023
Assessing PD-L1 Expression in Head and Neck Squamous Cell Carcinoma: Trials and Tribulations.
Journal: Head and neck pathology
Published: September 07, 2023
CXCL9:SPP1 macrophage polarity identifies a network of cellular programs that control human cancers.
CXCL9:SPP1 macrophage polarity identifies a network of cellular programs that control human cancers.
Journal: Science (New York, N.Y.)
Published: August 03, 2023
Dual TLR9 and PD-L1 targeting unleashes dendritic cells to induce durable antitumor immunity.
Journal: Journal for immunotherapy of cancer
Published: April 16, 2023
A neutrophil response linked to tumor control in immunotherapy.
Journal: Cell
Published: September 03, 2022
Dendritic cells direct circadian anti-tumour immune responses.
Journal: Nature
Published: April 14, 2022
Diagnostic challenges and successful organ-preserving therapy in a case of secretory carcinoma of minor salivary glands.
Journal: Cancer reports (Hoboken, N.J.)
Published: May 04, 2021
Last Updated: 09/26/2026